Skip to main content

Advertisement

Figure 5 | BMC Cancer

Figure 5

From: Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

Figure 5

RRM1 and ERCC1 immunoreactivity correlated to proportion of effective drugs and survival time. (A) Proportion of effective drugs plotted against RRM1 staining. (B) Survival time plotted against RRM1. (C) Proportion of effective drugs plotted against ERCC1 staining. (D) Survival time plotted against ERCC1 Regression analysis presented in red, data points for each patient in blue. Statistically significant departure of the slope from 0 was accepted at p < 0.05 and seen for proportion of effective drugs and RRM1 immunoreactivity (A).

Back to article page